198 N Springfield Ave - DaVita Dialysis 6,706 SF Health Care Building Offered at $3,026,416 CAD at a 7.50% Cap Rate in Rockford, IL 61101

The Boulder Group is pleased to exclusively market for sale a single tenant net leased DaVita Dialysis property located in Rockford, Illinois. DaVita has been successfully operating from this location since the completion of construction in 2017. In February 2026, DaVita signed a lease extension through August 2032, demonstrating commitment to the site. The lease features three 5-year renewal options with 5% rental escalation at the start of each. DaVita is e-commerce and recession resistant tenant.
The 6,706 square-foot building bene?ts from its position near the signalized intersection of North Spring?eld Avenue and West State Road, which experience a combined 22,000 vehicles per day. The subject property draws from a dense surrounding population, with over 90,000 residents living within a ?ve-mile radius. Nearby traffic drivers include Auburn High School, home to approximately 2,000 students, as well as Farm & Fleet and the amenities of downtown Rockford, all of which contribute to strong daily activity in the immediate area. Additionally, the adjacent site is slated to be home to a future McDonald’s location. Furthermore, the property bene?ts from limited dialysis competition nearby, reinforcing its role as a primary care destination for the surrounding community.
DaVita Inc. (NYSE: DVA), headquartered in Denver, Colorado, is a leading global healthcare provider specializing in kidney care, particularly dialysis services for patients with chronic kidney failure and end-stage renal disease. As one of the largest operators in the industry, the company serves approximately 295,000 patients across more than 3,200 outpatient dialysis centers worldwide as of 2026, including over 2,650 centers in the United States and additional facilities in 14 other countries. Founded in its current form in 2000 (with roots dating back to 1994), DaVita—meaning “to give life” in Italian—focuses on delivering comprehensive, innovative, and patient-centered care throughout the kidney disease journey, from early detection and slowing disease progression to in-center and home dialysis, transplantation support, and acute care. Recognized for clinical quality leadership over 25 years, DaVita maintains a strong commitment to improving patient outcomes, equity in care, and operational excellence as a publicly traded Fortune 500 company.